Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

57.1%

4 terminated/withdrawn out of 7 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06042335Not ApplicableNot Yet Recruiting

A Feasibility Study for the DAISe EZ Thrombectomy Device - Pacific

Role: lead

NCT05139147Not ApplicableTerminated

DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke

Role: lead

NCT04437862Not ApplicableCompleted

A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke

Role: lead

NCT05631483Not ApplicableTerminated

COlombia DAISe FEasibility Exercise

Role: lead

NCT04089917Completed

A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients

Role: lead

NCT04991038Not ApplicableWithdrawn

Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients

Role: lead

NCT03957278Not ApplicableTerminated

A Study to Evaluate the DAISe System During Neurointervention for Acute Ischemic Stroke

Role: lead

All 7 trials loaded